Alterations in Cognition-Related Cerebello-Cerebral Networks in Multiple System Atrophy.


Journal

Cerebellum (London, England)
ISSN: 1473-4230
Titre abrégé: Cerebellum
Pays: United States
ID NLM: 101089443

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 10 5 2019
medline: 14 1 2020
entrez: 10 5 2019
Statut: ppublish

Résumé

We aimed to elucidate the effect of cerebellar degeneration in relation to cognition in multiple system atrophy (MSA). Thirty-two patients diagnosed with probable MSA and 32 age- and gender-matched healthy controls (HCs) were enrolled. We conducted voxel-based morphometry (VBM) for anatomical images and independent component analysis (ICA), dual-regression analysis, and seed-based analysis for functional images with voxel-wise gray matter correction. In the MSA group, a widespread cerebellar volume loss was observed. ICA and dual-regression analysis showed lower functional connectivity (FC) in the left executive control and salience networks in regions located in the cerebellum. Seed-based analysis using the identified cerebellar regions as seeds showed extensive disruptions in cerebello-cerebral networks. Global cognitive scores correlated with the FC values between the right lobules VI/crus I and the medial prefrontal/anterior cingulate cortices and between the same region and the amygdala/parahippocampal gyrus. Our study indicates that cerebellar degeneration in MSA causes segregation of cerebellar-cerebral networks. Furthermore, the cognitive deficits in MSA may be driven by decreased cerebello-prefrontal and cerebello-amygdaloid functional connections.

Identifiants

pubmed: 31069705
doi: 10.1007/s12311-019-01031-7
pii: 10.1007/s12311-019-01031-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

770-780

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : Brain Protein Aging and Dementia Control 26117002
Organisme : Japan Agency for Medical Research and Development
ID : None

Références

Brain. 2002 May;125(Pt 5):1070-83
pubmed: 11960896
Mov Disord. 2004 Dec;19(12):1391-402
pubmed: 15452868
Philos Trans R Soc Lond B Biol Sci. 2005 May 29;360(1457):1001-13
pubmed: 16087444
Int J Geriatr Psychiatry. 2006 Nov;21(11):1078-85
pubmed: 16977673
Neuroimage. 2007 Jan 15;34(2):500-8
pubmed: 17113790
Exp Brain Res. 2007 Jun;180(2):355-65
pubmed: 17256160
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
Brain. 2008 Feb;131(Pt 2):438-46
pubmed: 18178568
Neurology. 2008 Apr 15;70(16 Pt 2):1390-6
pubmed: 18413566
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Neuroimage. 2009 Jan 15;44(2):489-501
pubmed: 18835452
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7209-14
pubmed: 19357304
Eur J Neurol. 2009 Oct;16(10):1144-50
pubmed: 19486137
J Neurosci. 2009 Jul 1;29(26):8586-94
pubmed: 19571149
Cereb Cortex. 2009 Oct;19(10):2485-97
pubmed: 19592571
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13040-5
pubmed: 19620724
J Cogn Neurosci. 2010 Nov;22(11):2663-76
pubmed: 19925191
Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):365-70
pubmed: 19935145
Brain. 2010 Aug;133(Pt 8):2382-93
pubmed: 20576697
Cerebellum. 2011 Jun;10(2):233-44
pubmed: 21110147
Neurobiol Aging. 2012 Mar;33(3):623.e1-623.e13
pubmed: 21524432
J Neurophysiol. 2011 Nov;106(5):2322-45
pubmed: 21795627
Neurobiol Aging. 2012 Apr;33(4):828.e19-30
pubmed: 21840627
Neuroimage. 2012 Jan 16;59(2):1560-70
pubmed: 21907811
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
J Neuroimaging. 2014 Jan-Feb;24(1):45-53
pubmed: 22211726
Brain. 2012 Nov;135(Pt 11):3206-26
pubmed: 22382359
Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):29-37
pubmed: 22619659
Neuron. 2012 Dec 20;76(6):1057-70
pubmed: 23259943
J Neurol Neurosurg Psychiatry. 2013 May;84(5):544-51
pubmed: 23303961
Clin Neurophysiol. 2013 Jul;124(7):1269-76
pubmed: 23422326
J Neural Transm (Vienna). 2013 Apr;120(4):613-8
pubmed: 23462799
J Neuroimaging. 2013 Oct;23(4):452-62
pubmed: 23701268
Brain. 2013 Jul;136(Pt 7):2050-62
pubmed: 23801734
Trends Cogn Sci. 2013 Aug;17(8):379-90
pubmed: 23850264
PLoS One. 2013 Jul 04;8(7):e68910
pubmed: 23861951
J Parkinsons Dis. 2012;2(1):7-18
pubmed: 23939403
Cerebellum. 2014 Feb;13(1):151-77
pubmed: 23996631
Hum Brain Mapp. 2014 Jul;35(7):3152-69
pubmed: 24142505
Neuron. 2013 Oct 30;80(3):807-15
pubmed: 24183029
Front Neurosci. 2013 Dec 10;7:237
pubmed: 24339802
Prog Neurobiol. 2014 Mar;114:102-31
pubmed: 24389385
Neurosci Biobehav Rev. 2014 May;42:180-92
pubmed: 24568942
Mov Disord. 2014 Jun;29(7):884-8
pubmed: 24752994
Mov Disord. 2014 Jun;29(7):857-67
pubmed: 24753321
Neurology. 2015 Jan 20;84(3):313-24
pubmed: 25527268
Brain. 2015 Aug;138(Pt 8):2293-309
pubmed: 25981961
CNS Neurosci Ther. 2015 Oct;21(10):754-67
pubmed: 26031656
JAMA Intern Med. 2015 Sep;175(9):1450-8
pubmed: 26052687
Mov Disord. 2015 Aug;30(9):1237-47
pubmed: 26094856
Neurodegener Dis. 2015;15(5):294-300
pubmed: 26202063
Eur J Neurol. 2016 Jan;23(1):92-100
pubmed: 26234320
Parkinsonism Relat Disord. 2015 Oct;21(10):1273-7
pubmed: 26305998
Cerebellum. 2017 Feb;16(1):203-229
pubmed: 26873754
Front Neuroinform. 2016 Jun 15;10:20
pubmed: 27378902
J Neural Transm (Vienna). 2017 Mar;124(3):293-302
pubmed: 27778099
Neuroradiology. 2017 Feb;59(2):157-168
pubmed: 28062908
Mov Disord. 2017 May;32(5):757-768
pubmed: 28186664
Trends Cogn Sci. 2017 May;21(5):313-332
pubmed: 28385461
Cortex. 2018 Mar;100:140-148
pubmed: 28779872
Front Aging Neurosci. 2017 Aug 10;9:266
pubmed: 28848423
Cerebellum. 2018 Apr;17(2):101-103
pubmed: 29071518
Neuroimage. 2018 Apr 1;169:134-144
pubmed: 29225065
Neuroimage. 2018 May 15;172:437-449
pubmed: 29408539
Cerebellum Ataxias. 2018 Feb 14;5:4
pubmed: 29468083
Cerebellum Ataxias. 2018 Mar 29;5:8
pubmed: 29610671
J Neurol. 2018 Sep;265(9):2079-2087
pubmed: 29974207
Neurosci Lett. 2019 Jan 1;688:62-75
pubmed: 29997061
Brain. 1998 Apr;121 ( Pt 4):561-79
pubmed: 9577385

Auteurs

Kazuya Kawabata (K)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kazuhiro Hara (K)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hirohisa Watanabe (H)

Brain and Mind Research Center, Nagoya University, Nagoya, Japan. nabe@med.nagoya-u.ac.jp.

Epifanio Bagarinao (E)

Brain and Mind Research Center, Nagoya University, Nagoya, Japan.

Aya Ogura (A)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Michihito Masuda (M)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Takamasa Yokoi (T)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Toshiyasu Kato (T)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Reiko Ohdake (R)

Brain and Mind Research Center, Nagoya University, Nagoya, Japan.

Mizuki Ito (M)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masahisa Katsuno (M)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Gen Sobue (G)

Brain and Mind Research Center, Nagoya University, Nagoya, Japan. sobueg@med.nagoya-u.ac.jp.
Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan. sobueg@med.nagoya-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH